TIME TO PLAY show-and-tell. In a year notably short on profits, this day at least won't be as big companies release earnings reports by the dozen.
If only they were all like Pfizer's (PFE). The world's top drug maker reported a 30% rise in profits this morning, on the strength of blockbuster medicines like impotency pill Viagra and savings from last year's merger with Warner-Lambert. Pfizer earned 30 cents a share, a penny better than the consensus forecast. Revenues rose 10 percent to $7.7 billion.
If only they were all like Pfizer's (PFE). The world's top drug maker reported a 30% rise in profits this morning, on the strength of blockbuster medicines like impotency pill Viagra and savings from last year's merger with Warner-Lambert. Pfizer earned 30 cents a share, a penny better than the consensus forecast. Revenues rose 10 percent to $7.7 billion.